1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
A drug screen with approved compounds identifies amlexanox as a novel Wnt/β-catenin activator inducing lung epithelial organoid formation
(
- Contribution to journal › Article
-
Mark
Extracellular-Matrix-Reinforced Bioinks for 3D Bioprinting Human Tissue
(
- Contribution to journal › Article
-
Mark
Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics
(
- Contribution to journal › Article
- 2020
-
Mark
Applications and Approaches for Three-Dimensional Precision-Cut Lung Slices. Disease Modeling and Drug Discovery
(
- Contribution to journal › Scientific review
-
Mark
Inhibition of LTβR signalling activates WNT-induced regeneration in lung
(
- Contribution to journal › Article
- 2019
-
Mark
Generation of Human 3D Lung Tissue Cultures (3D-LTCs) for Disease Modeling
2019) In Journal of visualized experiments : JoVE(
- Contribution to journal › Article
-
Mark
The Oncogene ECT2 Contributes to a Hyperplastic, Proliferative Lung Epithelial Cell Phenotype in Idiopathic Pulmonary Fibrosis
(
- Contribution to journal › Article
- 2018
-
Mark
New players in chronic lung disease identified at the European Respiratory Society International Congress in Paris 2018 : From microRNAs to extracellular vesicles
(
- Contribution to journal › Article
-
Mark
S100a4 Is Secreted by Alternatively Activated Alveolar Macrophages and Promotes Activation of Lung Fibroblasts in Pulmonary Fibrosis
(
- Contribution to journal › Article
-
Mark
Dynamic expression of HOPX in alveolar epithelial cells reflects injury and repair during the progression of pulmonary fibrosis
(
- Contribution to journal › Article